Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Fredrik Nyberg, Johan Askling, Niklas Berglind, Stefan Franzén, Meilien Ho, Marie Holmqvist, Laura Horne, Kathy Lampl, Kaleb Michaud, Dimitrios A Pappas, George Reed, Deborah Symmons, Eiichi Tanaka, Trung N Tran, Suzanne Verstappen, Eveline Wesby-van Swaay, Hisashi Yamanaka, Jeffrey D Greenberg

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry